JPMorgan Chase & Co’s Oruka Therapeutics, Inc. Common Stock ORKA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $173K | Buy |
15,425
+13,115
| +568% | +$147K | ﹤0.01% | 4527 |
|
|
2025
Q1 | $23.7K | Sell |
2,310
-490
| -18% | -$5.03K | ﹤0.01% | 5242 |
|
|
2024
Q4 | $54.3K | Buy |
+2,800
| New | +$54.3K | ﹤0.01% | 4985 |
|
|
2024
Q3 | – | Sell |
-1
| Closed | -$61 | – | 6543 |
|
|
2024
Q2 | $61 | Sell |
1
-1
| -50% | -$61 | ﹤0.01% | 5962 |
|
|
2024
Q1 | $32 | Buy |
2
+1
| +100% | +$16 | ﹤0.01% | 6095 |
|
|
2023
Q4 | $27 | Hold |
1
| – | – | ﹤0.01% | 6255 |
|
|
2023
Q3 | $24 | Buy |
+1
| New | +$24 | ﹤0.01% | 6178 |
|
|
2022
Q2 | – | Sell |
-56
| Closed | -$2K | – | 5950 |
|
|
2022
Q1 | $2K | Buy |
+56
| New | +$2K | ﹤0.01% | 5609 |
|
|
2021
Q3 | – | Sell |
-11
| Closed | – | – | 5794 |
|
|
2021
Q2 | $0 | Buy |
+11
| New | – | ﹤0.01% | 5675 |
|
|
2020
Q1 | – | Sell |
-807
| Closed | -$55K | – | 4856 |
|
|
2019
Q4 | $55K | Buy |
+807
| New | +$55K | ﹤0.01% | 4209 |
|